Skip to main content Skip to navigation
License WSU technologies with the click of a button
March 6, 2017

By Alyssa Patrick, Office of Commercialization

PULLMAN, Wash. – Research aids developed at Washington State University are more readily available to the researchers and companies that need them through an online store launched by WSU’s Office of Commercialization.

Licensing deal will help Genus combat deadly cattle disease
July 27, 2016

srikumaran-s-2010-80PULLMAN, Wash. – A gene editing technology developed at Washington State University is being licensed to Genus plc, a global animal genetics company, to develop cattle that are more resistant to bovine respiratory disease (BRD).

Licensing agreement will improve chemical detection
June 15, 2016

By Alyssa Patrick, Office of Commercialization

Hill-80PULLMAN, Wash. – A new licensing partnership between Washington State University and Excellims Corp. will improve chemical detection tools used to identify everything from dangerous chemicals to human disease.

Genetic tests to be offered for prostate, breast cancers
August 18, 2015

By Lorraine Nelson, WSU Spokane

Trobridge-80SPOKANE, Wash. – A genetic testing company will make available tests for prostate cancer survival and breast cancer recurrence to patients following identification of the biomarker genes in a Washington State University laboratory.

WSU spectroscopic technology licensed to G-Biosciences
December 1, 2006

PULLMAN – Washington State University Research Foundation and G-Biosciences have entered into a worldwide technology licensing agreement for patent rights to a spectroscopic method for assaying the activity of a key class of enzymes involved in several biological systems, including signal transduction, protein repair, chromatin regulation and gene silencing.WSU chemist and Associate Professor Zhaohui Sunny Zhou and research associate Kathleen Dorgan led the team that developed the new assay, which allows researchers to measure the activities of a large and diverse family of enzymes called methyltransferases in cell extracts.“We found this technology to be a fabulous opportunity to add to our existing line of assays … » More …